Rho-kinase inhibitor Y-27632 attenuates arsenic trioxide toxicity in H9c2 cardiomyoblastoma cells

Cardiovascular Toxicology

Volumn 13, Issue 3, 2013, Pages 267-277

  Bessho, Marie ^a   Aki, Toshihiko ^a   Funakoshi, Takeshi ^a   Unuma, Kana ^a   Noritake, Kanako ^a   Kato, Chizuru ^a   Uemura, Koichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Arsenic trioxide; Autophagy; Cardiac cells; Rho kinase; Y 27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ARSENIC TRIOXIDE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 9; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; VIMENTIN;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CARDIOMYOBLASTOMA CELL; CELL DEATH; CELL MEMBRANE; CELL PROTECTION; CELL STRAIN; CELL STRAIN H9C2; CELL VIABILITY; CYTOTOXICITY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REPRESSION; EXPOSURE; HEART MUSCLE CELL; MICROFILAMENT; MITOCHONDRIAL MEMBRANE POTENTIAL; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; RAT; TUMOR CELL;

RATTUS;

AMIDES; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; APOPTOSIS; ARSENICALS; AUTOPHAGY; BLOTTING, WESTERN; CARDIOTONIC AGENTS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME INHIBITORS; GENETIC VECTORS; OXIDES; PYRIDINES; RATS; REACTIVE OXYGEN SPECIES; RHO-ASSOCIATED KINASES; TRANSFECTION; VIMENTIN;

EID: 84884280119     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-013-9206-2     Document Type: Article

References (43)

1. Navas-Acien, A., Silbergeld, E. K., Pastor-Barriuso, R., & Guallar, E. (2008). Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA, 300, 814-822.
2. Kitchin, K. T. (2001). Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicology and Applied Pharmacology, 172, 249-261.
3. Balakumar, P., & Kaur, J. (2009). Arsenic exposure and cardiovascular disorders: An overview. Cardiovascular Toxicology, 9, 169-176.
4. Platanias, L. C. (2009). Biological responses to arsenic compounds. The Journal of Biological Chemistry, 284, 18583-18587.
5. Ralph, S. J. (2008). Arsenic-based antineoplastic drugs and their mechanisms of action. Metal Based Drugs, 2008, 260146.
6. Miller, W. H, Jr, Schipper, H. M., Lee, J. S., Singer, J., & Waxman, S. (2002). Mechanisms of action of arsenic trioxide. Cancer Research, 62, 3893-3903.
7. Nasr, R., & de The, H. (2010). Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting. International Journal of Hematology, 91, 742-747.
8. Isakson, P., Bjoras, M., Boe, S. O., & Simonsen, A. (2010). Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. Blood, 116, 2324-2331.
9. Barbey, J. T., & Soignet, S. (2001). Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Annals of Internal Medicine, 135, 842-843.
10. Ohnishi, K., Yoshida, H., Shigeno, K., Nakamura, S., Fujisawa, S., Naito, K., et al. (2000). Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Annals of Internal Medicine, 133, 881-885.
11. Unnikrishnan, D., Dutcher, J. P., Varshneya, N., Lucariello, R., Api, M., Garl, S., et al. (2001). Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood, 97, 1514-1516.
12. Riento, K., & Ridley, A. J. (2003). Rocks: Multifunctional kinases in cell behaviour. Nature Reviews Molecular Cell Biology, 4, 446-456.
13. Loirand, G., Guerin, P., & Pacaud, P. (2006). Rho kinases in cardiovascular physiology and pathophysiology. Circulation Research, 98, 322-334.
14. Wickman, G., Julian, L., & Olson, M. F. (2012). How apoptotic cells aid in the removal of their own cold dead bodies. Cell Death and Differentiation, 19, 735-742.
15. Chang, J., Xie, M., Shah, V. R., Schneider, M. D., Entman, M. L., Wei, L., et al. (2006). Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 103, 14495-14500.
16. Sebbagh, M., Renvoize, C., Hamelin, J., Riche, N., Bertoglio, J., & Breard, J. (2001). Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nature Cell Biology, 3, 346-352.
17. Kanzawa, T., Kondo, Y., Ito, H., Kondo, S., & Germano, I. (2003). Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Research, 63, 2103-2108.
18. Kanzawa, T., Zhang, L., Xiao, L., Germano, I. M., Kondo, Y., & Kondo, S. (2005). Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene, 24, 980-991.
19. Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008). Autophagy fights disease through cellular self-digestion. Nature, 451, 1069-1075.
20. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
21. Noritake, K., Aki, T., Funakoshi, T., Unuma, K., Nara, A., Kato, C., et al. (2012). Critical roles of Rho-associated kinase in membrane blebbing and mitochondrial pathway of apoptosis caused by 1-butanol. Toxicology in Vitro, 26, 849-855.
22. Funakoshi, T., Aki, T., Nakayama, H., Watanuki, Y., Imori, S., & Uemura, K. (2011). Reactive oxygen species-independent rapid initiation of mitochondrial apoptotic pathway by chelerythrine. Toxicology in Vitro, 25, 1581-1587.
23. Watanabe, N., & Mitchison, T. J. (2002). Single-molecule speckle analysis of actin filament turnover in lamellipodia. Science, 295, 1083-1086.
24. Subach, O. M., Patterson, G. H., Ting, L. M., Wang, Y., Condeelis, J. S., & Verkhusha, V. V. (2011). A photoswitchable orange-to-far-red fluorescent protein, PSmOrange. Nature Methods, 8, 771-777.
25. Zhao, X., Feng, T., Chen, H., Shan, H., Zhang, Y., Lu, Y., et al. (2008). Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: Implications in cardiotoxicity. Basic & Clinical Pharmacology & Toxicology, 102, 419-425.
26. Zhao, X. Y., Li, G. Y., Liu, Y., Chai, L. M., Chen, J. X., Zhang, Y., et al. (2008). Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. British Journal of Pharmacology, 154, 105-113.
27. Morishima, N. (1999). Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstream of Bcl-2 action. Genes to Cells, 4, 401-414.
28. Byun, Y., Chen, F., Chang, R., Trivedi, M., Green, K. J., & Cryns, V. L. (2001). Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death and Differentiation, 8, 443-450.
29. Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R., & Wallace, K. B. (2007). Vital imaging of H9c2 myoblasts exposed to tert- butylhydroperoxide-characterization of morphological features of cell death. BMC Cell Biology, 8, 11.
30. Yu, B. C., Chang, C. K., Ou, H. Y., Cheng, K. C., & Cheng, J. T. (2008). Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats. Cardiovascular Research, 80, 78-87.
31. Cao, Z., Zhu, H., Zhang, L., Zhao, X., Zweier, J. L., & Li, Y. (2006). Antioxidants and phase 2 enzymes in cardiomyocytes: Chemical inducibility and chemoprotection against oxidant and simulated ischemia-reperfusion injury. Experimental Biology and Medicine (Maywood, N.J.), 231, 1353-1364.
32. Bauer, P. O., Wong, H. K., Oyama, F., Goswami, A., Okuno, M., Kino, Y., et al. (2009). Inhibition of Rho kinases enhances the degradation of mutant huntingtin. Journal of Biological Chemistry, 284, 13153-13164.
33. Mleczak, A., Millar, S., Tooze, S. A., Olson, M. F., & Chan, E. Y. (2012). Regulation of autophagosome formation by Rho kinase. Cellular Signalling, 25, 1-11.
34. Yancy, S. L., Shelden, E. A., Gilmont, R. R., & Welsh, M. J. (2005). Sodium arsenite exposure alters cell migration, focal adhesion localization and decreases tyrosine phosphorylation of focal adhesion kinase in H9C2 myoblasts. Toxicological Science, 84, 278-286.
35. Lemarie, A., Morzadec, C., Bourdonnay, E., Fardel, O., & Vernhet, L. (2006). Human macrophages constitute targets for immunotoxic inorganic arsenic. Journal of Immunology, 177, 3019-3027.
36. Potin, S., Bertoglio, J., & Breard, J. (2007). Involvement of a Rho-ROCK-JNK pathway in arsenic trioxide-induced apoptosis in chronic myelogenous leukemia cells. FEBS Letters, 581, 118-124.
37. Yih, L. H., Wu, Y. C., Hsu, N. C., & Kuo, H. H. (2012). Arsenic trioxide induces abnormal mitotic spindles through a PIP4KIIgamma/Rho pathway. Toxicological Science, 128, 115-125.
38. Ohgushi, M., Matsumura, M., Eiraku, M., Murakami, K., Aramaki, T., Nishiyama, A., et al. (2010). Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell, 7, 225-239.
39. Kroemer, G., & Levine, B. (2008). Autophagic cell death: The story of a misnomer. Nature Reviews Molecular Cell Biology, 9, 1004-1010.
40. Boya, P., Gonzalez-Polo, R. A., Casares, N., Perfettini, J. L., Dessen, P., Larochette, N., et al. (2005). Inhibition of macroautophagy triggers apoptosis. Molecular Cell Biology, 25, 1025-1040.
41. Li, Y., Sun, X., Wang, L., Zhou, Z., & Kang, Y. J. (2002). Myocardial toxicity of arsenic trioxide in a mouse model. Cardiovascular Toxicology, 2, 63-73.
42. Youle, R. J., & Narendra, D. P. (2011). Mechanisms of mitophagy. Nature Reviews Molecular Cell Biology, 12, 9-14.
43. Yuan, H., Perry, C. N., Huang, C., Iwai-Kanai, E., Carreira, R. S., Glembotski, C. C., et al. (2009). LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. American Journal of Physiology Heart and Circulatory Physiology, 296, H470-H479.